Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

Chordomas of the skull base are relative rare lesions of the bones. Surgical resection is the primary treatment standard, though complete resection is nearly impossible due to close proximity to critical and hence also dose limiting organs for radiation therapy. Level of recurrence after surgery alo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nikoghosyan, Anna (VerfasserIn) , Karapanagiotou-Schenkel, Irini (VerfasserIn) , Münter, Marc (VerfasserIn) , Jensen, Alexandra (VerfasserIn) , Combs, Stephanie (VerfasserIn) , Debus, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 November 2010
In: BMC cancer
Year: 2010, Jahrgang: 10, Pages: 1-9
ISSN:1471-2407
DOI:10.1186/1471-2407-10-607
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-10-607
Volltext
Verfasserangaben:Anna V. Nikoghosyan, Irini Karapanagiotou-Schenkel, Marc W. Münter, Alexandra D. Jensen, Stephanie E. Combs, Jürgen Debus
Beschreibung
Zusammenfassung:Chordomas of the skull base are relative rare lesions of the bones. Surgical resection is the primary treatment standard, though complete resection is nearly impossible due to close proximity to critical and hence also dose limiting organs for radiation therapy. Level of recurrence after surgery alone is comparatively high, so adjuvant radiation therapy is very important for the improvement of local control rates. Proton therapy is the gold standard in the treatment of skull base chordomas. However, high-LET beams such as carbon ions theoretically offer biologic advantages by enhanced biologic effectiveness in slow-growing tumors.
Beschreibung:Gesehen am 17.05.2023
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-10-607